Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus.

Muñoz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri SK, Lee SW, García-Sastre A, Moran TM, Aaronson SA.

J Immunol. 2011 Dec 15;187(12):6428-36. doi: 10.4049/jimmunol.1101459. Epub 2011 Nov 21.

2.
3.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

4.

Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infection.

Yan W, Wei J, Deng X, Shi Z, Zhu Z, Shao D, Li B, Wang S, Tong G, Ma Z.

BMC Med Genomics. 2015 Aug 18;8:52. doi: 10.1186/s12920-015-0127-8.

5.

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS.

J Immunol. 2011 Nov 1;187(9):4581-8. doi: 10.4049/jimmunol.1002241. Epub 2011 Sep 21.

6.

A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection.

Verbist KC, Cole CJ, Field MB, Klonowski KD.

J Immunol. 2011 Jan 1;186(1):174-82. doi: 10.4049/jimmunol.1002613. Epub 2010 Nov 22.

7.

Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.

Langlois RA, Legge KL.

J Immunol. 2010 Apr 15;184(8):4440-6. doi: 10.4049/jimmunol.0902984. Epub 2010 Mar 10.

8.

Reduced interferon-α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus.

Kreuzer D, Nikoopour E, Au BC, Krougly O, Lee-Chan E, Summers KL, Haeryfar SM, Singh B.

Clin Exp Immunol. 2015 Feb;179(2):245-55. doi: 10.1111/cei.12462.

9.

Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection.

Kedzierski L, Linossi EM, Kolesnik TB, Day EB, Bird NL, Kile BT, Belz GT, Metcalf D, Nicola NA, Kedzierska K, Nicholson SE.

PLoS Pathog. 2014 May 8;10(5):e1004134. doi: 10.1371/journal.ppat.1004134. eCollection 2014 May.

10.

Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity.

Uematsu T, Iizasa E, Kobayashi N, Yoshida H, Hara H.

Sci Rep. 2015 Dec 2;5:17577. doi: 10.1038/srep17577.

11.

Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance.

Lupfer CR, Stokes KL, Kuriakose T, Kanneganti TD.

J Virol. 2017 Aug 10;91(17). pii: e00377-17. doi: 10.1128/JVI.00377-17. Print 2017 Sep 1.

12.

The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection.

Ito T, Allen RM, Carson WF 4th, Schaller M, Cavassani KA, Hogaboam CM, Lukacs NW, Matsukawa A, Kunkel SL.

PLoS Pathog. 2011 Nov;7(11):e1002341. doi: 10.1371/journal.ppat.1002341. Epub 2011 Nov 3.

13.

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.

Chua BY, Wong CY, Mifsud EJ, Edenborough KM, Sekiya T, Tan AC, Mercuri F, Rockman S, Chen W, Turner SJ, Doherty PC, Kelso A, Brown LE, Jackson DC.

MBio. 2015 Oct 27;6(6):e01024-15. doi: 10.1128/mBio.01024-15.

15.

Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunity.

Hong DK, Chang S, Botham CM, Giffon TD, Fairman J, Lewis DB.

J Virol. 2010 Dec;84(24):12691-702. doi: 10.1128/JVI.00769-10. Epub 2010 Oct 13.

16.

Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation.

Yatmaz S, Seow HJ, Gualano RC, Wong ZX, Stambas J, Selemidis S, Crack PJ, Bozinovski S, Anderson GP, Vlahos R.

Am J Respir Cell Mol Biol. 2013 Jan;48(1):17-26. doi: 10.1165/rcmb.2011-0345OC. Epub 2012 Sep 20.

PMID:
23002098
17.

miR-451 regulates dendritic cell cytokine responses to influenza infection.

Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A.

J Immunol. 2012 Dec 15;189(12):5965-75. doi: 10.4049/jimmunol.1201437. Epub 2012 Nov 19.

18.

Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.

Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, Wu H, Topham DJ.

J Virol. 2010 Jul;84(13):6687-98. doi: 10.1128/JVI.00266-10. Epub 2010 Apr 21.

19.

Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.

Antunes I, Kassiotis G.

J Virol. 2010 Dec;84(24):12564-75. doi: 10.1128/JVI.01559-10. Epub 2010 Oct 13.

20.

Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.

Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, Kay T, Smyth MJ, Sadler AJ, Chen W.

J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.

Supplemental Content

Support Center